NCT03283917
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoglobulin Light-chain Amyloidosis
Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.
187 public trials
43 recruiting studies
Immunoglobulin Light-chain Amyloidosis trial results
NCT07585331
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
NCT04392960
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo Pavia, Italy
NCT03431896
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloid, +33 more
- Locations
-
- Cleveland Clinic Cleveland, Ohio, United States
Completed
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
NCT01758042
- Conditions
- AL Amyloidosis, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), +73 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT03499808
- Conditions
- Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis, Blood Coagulation Disorders, +40 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Completed
A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
NCT04304144
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Research Site Stanford, California, United States
- Research Site Detroit, Michigan, United States
- Research Site Cleveland, Ohio, United States
Completed
Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis
NCT02245867
- Conditions
- AL Amyloidosis, Amyloidosis, Disease Attributes, +14 more
- Locations
-
- Columbia University Medical Center New York, United States
NCT04615572
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
- Locations
-
- University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Tufts Medical Center Boston, Massachusetts, United States
Completed
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Tulane University New Orleans, Louisiana, United States
- Washington University St Louis, Missouri, United States